BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22528158)

  • 1. Influenza virus surveillance, vaccine strain selection, and manufacture.
    Stöhr K; Bucher D; Colgate T; Wood J
    Methods Mol Biol; 2012; 865():147-62. PubMed ID: 22528158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.
    Brammer TL; Murray EL; Fukuda K; Hall HE; Klimov A; Cox NJ
    MMWR Surveill Summ; 2002 Oct; 51(7):1-10. PubMed ID: 12418623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for controlling future pandemics of influenza.
    Robertson JS; Inglis SC
    Virus Res; 2011 Dec; 162(1-2):39-46. PubMed ID: 21963676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis].
    Machała MK; Brydak LB
    Pol Merkur Lekarski; 2006 Sep; 21(123):277-85. PubMed ID: 17163191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
    ; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
    Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influenza season 1999/2000 and vaccine composition for the season 2000/01].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Dorigo-Zetsma JW; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1968-71. PubMed ID: 11048562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic engineering of live attenuated influenza viruses.
    Jin H; Chen Z; Liu J; Kemble G
    Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influenza season 1997/'98 and the vaccine composition for 1998/'99].
    Claas EC; Bartelds AI; Dorigo-Zetsma JW; Rimmelzwaan GF; de Jong JC; Osterhaus AD
    Ned Tijdschr Geneeskd; 1998 Oct; 142(44):2423-7. PubMed ID: 9864542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influenza season 1998/99; composition of vaccine for 1999/2000].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Dorigo-Zetsma JW; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 1999 Oct; 143(40):2015-8. PubMed ID: 10535060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiologic characteristics of influenza in China, from 2001 to 2003].
    Zhang J; Yang WZ; Guo YJ; Xu H; Zhang Y; Li Z; Guo JF; Wang M; Wang WJ; Li ZM; Sun XH; Xiao DL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):461-5. PubMed ID: 15231116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New vaccine approaches for seasonal and pandemic influenza.
    Palache B
    Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of northern hemisphere influenza vaccines by travelers to the southern hemisphere.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(12):312. PubMed ID: 19343012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in new vaccine strategies against influenza: a review].
    Liu Z; Jiang T; Qin E; Ran D; Qin C
    Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
    Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
    Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the WHO Global Influenza Programme.
    Stöhr K
    Dev Biol (Basel); 2003; 115():3-8. PubMed ID: 15088769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza in Taiwan: seasonality and vaccine strain match.
    Hsieh YC; Chen HY; Yen JJ; Liu DP; Chang LY; Lu CY; Shao PL; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2005 Aug; 38(4):238-43. PubMed ID: 16118670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.